Showing results (381-390 of 599) with videos related to

Sort By:
Pageof 60
The Lancet. Rheumatology|January 30, 2024
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)Silvia Bellando-Randone, Francesco Del Galdo, Gemma Lepri, et al.
The Journal of Rheumatology|September 19, 2006
IL13RA2 gene polymorphisms are associated with systemic sclerosisBrigitte Granel, Yannick Allanore, Christophe Chevillard, et al.
Arthritis and Rheumatism|May 7, 2011
Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observationsChristophe Meune, Jérôme Avouac, Paolo Airò, et al.
Arthritis and Rheumatism|December 6, 2011
Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosisJérôme Avouac, Katrin Palumbo, Michal Tomcik, et al.
Vaccine|August 18, 2024
"REAl LIfe" observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE)Giuliana Lucia Esposito, Federico Fassio, Daniela Girardi, et al.
European Journal of Internal Medicine|August 15, 2024
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registryMartina Orlandi, Silvia Bellando-Randone, Rossella De Angelis, et al.
Frontiers in Immunology|November 3, 2025
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literatureRoberto Depascale, Anna Ghirardello, Elisabetta Zanatta, et al.
Journal of Autoimmunity|May 24, 2024
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsetsChiara Franco, Alessandra Giannella, Michela Gasparotto, et al.
Clinical and Experimental Rheumatology|August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationaleDinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
The Lancet. Rheumatology|January 27, 2024
Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort studyRucsandra Dobrota, Suzana Jordan, Pernille Juhl, et al.
Pageof 60